Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system

Rosemary, Rosmarinus officinalis L. (Labiatae) has several therapeutic applications in folk medicine in curing or managing a wide range of diseases, including depression. In this study, the effect of the hydroalcoholic extract of the stems and leaves of this plant was investigated in two behavioral...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Progress in neuro-psychopharmacology & biological psychiatry 2009-06, Vol.33 (4), p.642-650
Hauptverfasser: Machado, Daniele G., Bettio, Luis E.B., Cunha, Mauricio P., Capra, Juliano C., Dalmarco, Juliana B., Pizzolatti, Moacir G., Rodrigues, Ana Lúcia S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 650
container_issue 4
container_start_page 642
container_title Progress in neuro-psychopharmacology & biological psychiatry
container_volume 33
creator Machado, Daniele G.
Bettio, Luis E.B.
Cunha, Mauricio P.
Capra, Juliano C.
Dalmarco, Juliana B.
Pizzolatti, Moacir G.
Rodrigues, Ana Lúcia S.
description Rosemary, Rosmarinus officinalis L. (Labiatae) has several therapeutic applications in folk medicine in curing or managing a wide range of diseases, including depression. In this study, the effect of the hydroalcoholic extract of the stems and leaves of this plant was investigated in two behavioral models, the forced swimming test (FST) and tail suspension test (TST) in mice. The extract of R. officinalis produced an antidepressant-like effect, since the acute treatment of mice with the extract by p.o. route significantly reduced the immobility time in the FST (100 mg/kg) and TST (10–100 mg/kg), as compared to a control group, without accompanying changes in ambulation in the open-field test. Moreover, the repeated administration (14 days) of the hydroalcoholic extract of R. officinalis by p.o. route also produced an antidepressant-like effect in the TST (100–300 mg/kg). The pretreatment of mice with p-chlorophenylalanine (PCPA, 100 mg/kg, i.p., an inhibitor of serotonin synthesis, for 4 consecutive days), NAN-190 (0.5 mg/kg, i.p., a 5-HT 1A receptor antagonist), ketanserin (5 mg/kg, i.p., a 5-HT 2A receptor antagonist), 1-(m-chlorophenyl) biguanide (mCPBG, 10 mg/kg, i.p., a 5-HT 3 receptor agonist), prazosin (1 mg/kg, i.p., an α 1-adrenoceptor antagonist), SCH23390 (0.05 mg/kg, s.c., a dopamine D 1 receptor antagonist) or sulpiride (50 mg/kg, i.p., a dopamine D 2 receptor antagonist), but not yohimbine (1 mg/kg, i.p., an α 2-adrenoceptor antagonist) was able to reverse the anti-immobility effect of the extract (10 mg/kg, p.o.) in the TST. The combination of MDL72222, (0.1 mg/kg, i.p., a 5-HT 3 receptor antagonist) with a sub-effective dose of the extract of R. officinalis (1 mg/kg, p.o.) produced an anti-immobility effect in the TST. The results suggest that the antidepressant action of the extract of R. officinalis is mediated by an interaction with the monoaminergic system and that this plant should be further investigated as an alternative therapeutic approach for the treatment of depression.
doi_str_mv 10.1016/j.pnpbp.2009.03.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67210424</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584609000633</els_id><sourcerecordid>67210424</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-cbd02c080d294dc893d7a9ac560ea868fd8dbcf62dde3e4e74fdfb2b740797a73</originalsourceid><addsrcrecordid>eNqFkdFqFDEUhoModq0-gSBzo3czPclkZjKCF6W0WigIotchk5xo1plkTLKLfXuz7lLv7FVy4PtPwv8R8ppCQ4H2F9tm9eu0NgxgbKBtAPgTsqFiEDVntH9KNsDKvRO8PyMvUtoCAG2hfU7O6MhEz3m_IfnSZ2dwjZiS8rme3U-s0FrUuQq2yj_K9DtHdRy_hLSo6Pwulck67byaXaqcrxan8X116_dh3uOC_iG9BB_U4jzG705X6T5lXF6SZ1bNCV-dznPy7eb669Wn-u7zx9ury7tac8FzrScDTIMAw0ZutBhbM6hR6a4HVKIX1ggzadszY7BFjgO3xk5sGjgM46CG9py8O-5dY_i1w5Tl4pLGeVYewy7JfmAUOOOPggy6kZXSCtgeQR1DShGtXKMrldxLCvJgRW7lXyvyYEVCK4uVknpzWr-bFjT_MicNBXh7AlTSarZRee3SA8do1wHjh-c_HDksre0dRpm0Q6_RuFiMSRPcfz_yB6eBrs8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20592192</pqid></control><display><type>article</type><title>Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Machado, Daniele G. ; Bettio, Luis E.B. ; Cunha, Mauricio P. ; Capra, Juliano C. ; Dalmarco, Juliana B. ; Pizzolatti, Moacir G. ; Rodrigues, Ana Lúcia S.</creator><creatorcontrib>Machado, Daniele G. ; Bettio, Luis E.B. ; Cunha, Mauricio P. ; Capra, Juliano C. ; Dalmarco, Juliana B. ; Pizzolatti, Moacir G. ; Rodrigues, Ana Lúcia S.</creatorcontrib><description>Rosemary, Rosmarinus officinalis L. (Labiatae) has several therapeutic applications in folk medicine in curing or managing a wide range of diseases, including depression. In this study, the effect of the hydroalcoholic extract of the stems and leaves of this plant was investigated in two behavioral models, the forced swimming test (FST) and tail suspension test (TST) in mice. The extract of R. officinalis produced an antidepressant-like effect, since the acute treatment of mice with the extract by p.o. route significantly reduced the immobility time in the FST (100 mg/kg) and TST (10–100 mg/kg), as compared to a control group, without accompanying changes in ambulation in the open-field test. Moreover, the repeated administration (14 days) of the hydroalcoholic extract of R. officinalis by p.o. route also produced an antidepressant-like effect in the TST (100–300 mg/kg). The pretreatment of mice with p-chlorophenylalanine (PCPA, 100 mg/kg, i.p., an inhibitor of serotonin synthesis, for 4 consecutive days), NAN-190 (0.5 mg/kg, i.p., a 5-HT 1A receptor antagonist), ketanserin (5 mg/kg, i.p., a 5-HT 2A receptor antagonist), 1-(m-chlorophenyl) biguanide (mCPBG, 10 mg/kg, i.p., a 5-HT 3 receptor agonist), prazosin (1 mg/kg, i.p., an α 1-adrenoceptor antagonist), SCH23390 (0.05 mg/kg, s.c., a dopamine D 1 receptor antagonist) or sulpiride (50 mg/kg, i.p., a dopamine D 2 receptor antagonist), but not yohimbine (1 mg/kg, i.p., an α 2-adrenoceptor antagonist) was able to reverse the anti-immobility effect of the extract (10 mg/kg, p.o.) in the TST. The combination of MDL72222, (0.1 mg/kg, i.p., a 5-HT 3 receptor antagonist) with a sub-effective dose of the extract of R. officinalis (1 mg/kg, p.o.) produced an anti-immobility effect in the TST. The results suggest that the antidepressant action of the extract of R. officinalis is mediated by an interaction with the monoaminergic system and that this plant should be further investigated as an alternative therapeutic approach for the treatment of depression.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2009.03.004</identifier><identifier>PMID: 19286446</identifier><identifier>CODEN: PNPPD7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adrenergic alpha-Antagonists - pharmacology ; Adult and adolescent clinical studies ; Analysis of Variance ; Animals ; Antidepressive Agents - pharmacology ; Antidepressive Agents - therapeutic use ; Behavior, Animal - drug effects ; Benzazepines - pharmacology ; Biogenic Monoamines - metabolism ; Biological and medical sciences ; Depression ; Depression - drug therapy ; Disease Models, Animal ; Dopamine ; Dopamine Antagonists - pharmacology ; Exploratory Behavior - drug effects ; Forced swimming test ; Hindlimb Suspension - methods ; Immobility Response, Tonic - drug effects ; Male ; Medical sciences ; Mice ; Mood disorders ; Neuropharmacology ; Noradrenaline ; Pharmacology. Drug treatments ; Phytotherapy ; Plant Extracts - pharmacology ; Prazosin - pharmacology ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychopharmacology ; Rosmarinus - chemistry ; Rosmarinus officinalis ; Serotonin ; Serotonin Agents - pharmacology ; Swimming ; Tail suspension test ; Time Factors</subject><ispartof>Progress in neuro-psychopharmacology &amp; biological psychiatry, 2009-06, Vol.33 (4), p.642-650</ispartof><rights>2009 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-cbd02c080d294dc893d7a9ac560ea868fd8dbcf62dde3e4e74fdfb2b740797a73</citedby><cites>FETCH-LOGICAL-c484t-cbd02c080d294dc893d7a9ac560ea868fd8dbcf62dde3e4e74fdfb2b740797a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pnpbp.2009.03.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21550242$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19286446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Machado, Daniele G.</creatorcontrib><creatorcontrib>Bettio, Luis E.B.</creatorcontrib><creatorcontrib>Cunha, Mauricio P.</creatorcontrib><creatorcontrib>Capra, Juliano C.</creatorcontrib><creatorcontrib>Dalmarco, Juliana B.</creatorcontrib><creatorcontrib>Pizzolatti, Moacir G.</creatorcontrib><creatorcontrib>Rodrigues, Ana Lúcia S.</creatorcontrib><title>Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system</title><title>Progress in neuro-psychopharmacology &amp; biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Rosemary, Rosmarinus officinalis L. (Labiatae) has several therapeutic applications in folk medicine in curing or managing a wide range of diseases, including depression. In this study, the effect of the hydroalcoholic extract of the stems and leaves of this plant was investigated in two behavioral models, the forced swimming test (FST) and tail suspension test (TST) in mice. The extract of R. officinalis produced an antidepressant-like effect, since the acute treatment of mice with the extract by p.o. route significantly reduced the immobility time in the FST (100 mg/kg) and TST (10–100 mg/kg), as compared to a control group, without accompanying changes in ambulation in the open-field test. Moreover, the repeated administration (14 days) of the hydroalcoholic extract of R. officinalis by p.o. route also produced an antidepressant-like effect in the TST (100–300 mg/kg). The pretreatment of mice with p-chlorophenylalanine (PCPA, 100 mg/kg, i.p., an inhibitor of serotonin synthesis, for 4 consecutive days), NAN-190 (0.5 mg/kg, i.p., a 5-HT 1A receptor antagonist), ketanserin (5 mg/kg, i.p., a 5-HT 2A receptor antagonist), 1-(m-chlorophenyl) biguanide (mCPBG, 10 mg/kg, i.p., a 5-HT 3 receptor agonist), prazosin (1 mg/kg, i.p., an α 1-adrenoceptor antagonist), SCH23390 (0.05 mg/kg, s.c., a dopamine D 1 receptor antagonist) or sulpiride (50 mg/kg, i.p., a dopamine D 2 receptor antagonist), but not yohimbine (1 mg/kg, i.p., an α 2-adrenoceptor antagonist) was able to reverse the anti-immobility effect of the extract (10 mg/kg, p.o.) in the TST. The combination of MDL72222, (0.1 mg/kg, i.p., a 5-HT 3 receptor antagonist) with a sub-effective dose of the extract of R. officinalis (1 mg/kg, p.o.) produced an anti-immobility effect in the TST. The results suggest that the antidepressant action of the extract of R. officinalis is mediated by an interaction with the monoaminergic system and that this plant should be further investigated as an alternative therapeutic approach for the treatment of depression.</description><subject>Adrenergic alpha-Antagonists - pharmacology</subject><subject>Adult and adolescent clinical studies</subject><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Antidepressive Agents - pharmacology</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Behavior, Animal - drug effects</subject><subject>Benzazepines - pharmacology</subject><subject>Biogenic Monoamines - metabolism</subject><subject>Biological and medical sciences</subject><subject>Depression</subject><subject>Depression - drug therapy</subject><subject>Disease Models, Animal</subject><subject>Dopamine</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Exploratory Behavior - drug effects</subject><subject>Forced swimming test</subject><subject>Hindlimb Suspension - methods</subject><subject>Immobility Response, Tonic - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mood disorders</subject><subject>Neuropharmacology</subject><subject>Noradrenaline</subject><subject>Pharmacology. Drug treatments</subject><subject>Phytotherapy</subject><subject>Plant Extracts - pharmacology</subject><subject>Prazosin - pharmacology</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rosmarinus - chemistry</subject><subject>Rosmarinus officinalis</subject><subject>Serotonin</subject><subject>Serotonin Agents - pharmacology</subject><subject>Swimming</subject><subject>Tail suspension test</subject><subject>Time Factors</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkdFqFDEUhoModq0-gSBzo3czPclkZjKCF6W0WigIotchk5xo1plkTLKLfXuz7lLv7FVy4PtPwv8R8ppCQ4H2F9tm9eu0NgxgbKBtAPgTsqFiEDVntH9KNsDKvRO8PyMvUtoCAG2hfU7O6MhEz3m_IfnSZ2dwjZiS8rme3U-s0FrUuQq2yj_K9DtHdRy_hLSo6Pwulck67byaXaqcrxan8X116_dh3uOC_iG9BB_U4jzG705X6T5lXF6SZ1bNCV-dznPy7eb669Wn-u7zx9ury7tac8FzrScDTIMAw0ZutBhbM6hR6a4HVKIX1ggzadszY7BFjgO3xk5sGjgM46CG9py8O-5dY_i1w5Tl4pLGeVYewy7JfmAUOOOPggy6kZXSCtgeQR1DShGtXKMrldxLCvJgRW7lXyvyYEVCK4uVknpzWr-bFjT_MicNBXh7AlTSarZRee3SA8do1wHjh-c_HDksre0dRpm0Q6_RuFiMSRPcfz_yB6eBrs8</recordid><startdate>20090615</startdate><enddate>20090615</enddate><creator>Machado, Daniele G.</creator><creator>Bettio, Luis E.B.</creator><creator>Cunha, Mauricio P.</creator><creator>Capra, Juliano C.</creator><creator>Dalmarco, Juliana B.</creator><creator>Pizzolatti, Moacir G.</creator><creator>Rodrigues, Ana Lúcia S.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20090615</creationdate><title>Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system</title><author>Machado, Daniele G. ; Bettio, Luis E.B. ; Cunha, Mauricio P. ; Capra, Juliano C. ; Dalmarco, Juliana B. ; Pizzolatti, Moacir G. ; Rodrigues, Ana Lúcia S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-cbd02c080d294dc893d7a9ac560ea868fd8dbcf62dde3e4e74fdfb2b740797a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adrenergic alpha-Antagonists - pharmacology</topic><topic>Adult and adolescent clinical studies</topic><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Antidepressive Agents - pharmacology</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Behavior, Animal - drug effects</topic><topic>Benzazepines - pharmacology</topic><topic>Biogenic Monoamines - metabolism</topic><topic>Biological and medical sciences</topic><topic>Depression</topic><topic>Depression - drug therapy</topic><topic>Disease Models, Animal</topic><topic>Dopamine</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Exploratory Behavior - drug effects</topic><topic>Forced swimming test</topic><topic>Hindlimb Suspension - methods</topic><topic>Immobility Response, Tonic - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mood disorders</topic><topic>Neuropharmacology</topic><topic>Noradrenaline</topic><topic>Pharmacology. Drug treatments</topic><topic>Phytotherapy</topic><topic>Plant Extracts - pharmacology</topic><topic>Prazosin - pharmacology</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rosmarinus - chemistry</topic><topic>Rosmarinus officinalis</topic><topic>Serotonin</topic><topic>Serotonin Agents - pharmacology</topic><topic>Swimming</topic><topic>Tail suspension test</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Machado, Daniele G.</creatorcontrib><creatorcontrib>Bettio, Luis E.B.</creatorcontrib><creatorcontrib>Cunha, Mauricio P.</creatorcontrib><creatorcontrib>Capra, Juliano C.</creatorcontrib><creatorcontrib>Dalmarco, Juliana B.</creatorcontrib><creatorcontrib>Pizzolatti, Moacir G.</creatorcontrib><creatorcontrib>Rodrigues, Ana Lúcia S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Machado, Daniele G.</au><au>Bettio, Luis E.B.</au><au>Cunha, Mauricio P.</au><au>Capra, Juliano C.</au><au>Dalmarco, Juliana B.</au><au>Pizzolatti, Moacir G.</au><au>Rodrigues, Ana Lúcia S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system</atitle><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2009-06-15</date><risdate>2009</risdate><volume>33</volume><issue>4</issue><spage>642</spage><epage>650</epage><pages>642-650</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><coden>PNPPD7</coden><abstract>Rosemary, Rosmarinus officinalis L. (Labiatae) has several therapeutic applications in folk medicine in curing or managing a wide range of diseases, including depression. In this study, the effect of the hydroalcoholic extract of the stems and leaves of this plant was investigated in two behavioral models, the forced swimming test (FST) and tail suspension test (TST) in mice. The extract of R. officinalis produced an antidepressant-like effect, since the acute treatment of mice with the extract by p.o. route significantly reduced the immobility time in the FST (100 mg/kg) and TST (10–100 mg/kg), as compared to a control group, without accompanying changes in ambulation in the open-field test. Moreover, the repeated administration (14 days) of the hydroalcoholic extract of R. officinalis by p.o. route also produced an antidepressant-like effect in the TST (100–300 mg/kg). The pretreatment of mice with p-chlorophenylalanine (PCPA, 100 mg/kg, i.p., an inhibitor of serotonin synthesis, for 4 consecutive days), NAN-190 (0.5 mg/kg, i.p., a 5-HT 1A receptor antagonist), ketanserin (5 mg/kg, i.p., a 5-HT 2A receptor antagonist), 1-(m-chlorophenyl) biguanide (mCPBG, 10 mg/kg, i.p., a 5-HT 3 receptor agonist), prazosin (1 mg/kg, i.p., an α 1-adrenoceptor antagonist), SCH23390 (0.05 mg/kg, s.c., a dopamine D 1 receptor antagonist) or sulpiride (50 mg/kg, i.p., a dopamine D 2 receptor antagonist), but not yohimbine (1 mg/kg, i.p., an α 2-adrenoceptor antagonist) was able to reverse the anti-immobility effect of the extract (10 mg/kg, p.o.) in the TST. The combination of MDL72222, (0.1 mg/kg, i.p., a 5-HT 3 receptor antagonist) with a sub-effective dose of the extract of R. officinalis (1 mg/kg, p.o.) produced an anti-immobility effect in the TST. The results suggest that the antidepressant action of the extract of R. officinalis is mediated by an interaction with the monoaminergic system and that this plant should be further investigated as an alternative therapeutic approach for the treatment of depression.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>19286446</pmid><doi>10.1016/j.pnpbp.2009.03.004</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0278-5846
ispartof Progress in neuro-psychopharmacology & biological psychiatry, 2009-06, Vol.33 (4), p.642-650
issn 0278-5846
1878-4216
language eng
recordid cdi_proquest_miscellaneous_67210424
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adrenergic alpha-Antagonists - pharmacology
Adult and adolescent clinical studies
Analysis of Variance
Animals
Antidepressive Agents - pharmacology
Antidepressive Agents - therapeutic use
Behavior, Animal - drug effects
Benzazepines - pharmacology
Biogenic Monoamines - metabolism
Biological and medical sciences
Depression
Depression - drug therapy
Disease Models, Animal
Dopamine
Dopamine Antagonists - pharmacology
Exploratory Behavior - drug effects
Forced swimming test
Hindlimb Suspension - methods
Immobility Response, Tonic - drug effects
Male
Medical sciences
Mice
Mood disorders
Neuropharmacology
Noradrenaline
Pharmacology. Drug treatments
Phytotherapy
Plant Extracts - pharmacology
Prazosin - pharmacology
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychopharmacology
Rosmarinus - chemistry
Rosmarinus officinalis
Serotonin
Serotonin Agents - pharmacology
Swimming
Tail suspension test
Time Factors
title Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T04%3A30%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antidepressant-like%20effect%20of%20the%20extract%20of%20Rosmarinus%20officinalis%20in%20mice:%20Involvement%20of%20the%20monoaminergic%20system&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Machado,%20Daniele%20G.&rft.date=2009-06-15&rft.volume=33&rft.issue=4&rft.spage=642&rft.epage=650&rft.pages=642-650&rft.issn=0278-5846&rft.eissn=1878-4216&rft.coden=PNPPD7&rft_id=info:doi/10.1016/j.pnpbp.2009.03.004&rft_dat=%3Cproquest_cross%3E67210424%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20592192&rft_id=info:pmid/19286446&rft_els_id=S0278584609000633&rfr_iscdi=true